Damlar İ, Esen E,
Tatli U. Effects of
glucosamine-chondroitin combination on synovial fluid IL-1β,
IL-6, TNF-α and PGE2 levels in
internal derangements of temporomandibular joint. Med Oral Patol Oral Cir Bucal. 2015 May 1;20
(3):e278-83.
doi:10.4317/medoral.20242
http://dx.doi.org/doi:10.4317/medoral.20242
|
1.
Kostrzewa-Janicka J, Mierzwinska-Nastalska
E, Jurkowski P, Okonski
P, Nedzi-Gora M. Assessment
of temporomandibular joint
disease. Adv Exp Med Biol. 2013;788:207-11. |
|
|
|
|
|
2.
Kacena MA, Merrel GA, Konda SR, Wilson KM, Xi Y, Horowitz
MC. Inflammation and bony
changes at the temporomandibular joint. Cells Tissues Organs. 2001;169:257-64. |
|
|
|
|
|
3.
Matsumoto K, Honda K, Ohshima
M, Yamaguchi Y, Nakajima I, Micke
P, et al. Cytokine profile
in synovial fluid from patients with internal derangement of the temporomandibular joint: a preliminary study. Dentomaxillofac Radiol. 2006;35:432-41. |
|
|
|
|
|
4.
Kaneyama K, Segami N, Yoshimura H, Honjo M, Demura N. Increased levels of soluble cytokine receptors in the synovial fluid of temporomandibular
joint disorders in relation to joint
effusion on magnetic resonance images. J Oral Maxillofac Surg. 2010;68:1088-93. |
|
|
|
|
|
5.
Kardel R, Ulfgren AK, Reinholt FP, Holmlund A. Inflammatory cell and cytokine patterns in patients with painful clicking and osteoarthritis in the temporomandibular joint. Int J Oral Maxillofac Surg. 2003;32:390-6. |
|
|
|
|
|
6.
Zhang B, Hu J, Man C, Zhu S. Effect of intra-articular administration
of interleukin 1 receptor antagonist
on cartilage repair in temporomandibular joint. J Craniofac Surg. 2011;22:711-4. |
|
|
|
|
|
7.
Arinci A, Ademoglu E, Aslan A, Mutlu-Turkoglu U, Karabulut AB, Karan A.
Molecular correlates of temporomandibular
joint disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:666-70. |
|
|
|
|
|
8.
Bouloux GF. Temporomandibular
joint pain and synovial fluid analysis: a review of the literature. J Oral Maxillofac Surg. 2009;67:2497-504. |
|
|
|
|
|
9.
Chou MM, Vergnolle N, McDougall JJ, Wallace JL, Marty
S, Teskey V, et al. Effects
of chondroitin and glucosamine
sulfate in a dietary bar formulation
on inflammation,
interleukin-1beta, matrix metalloprotease-9, and cartilage damage in arthritis. Exp Biol Med (Maywood).
2005;230:255-62. |
|
|
|
|
|
10.
Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, chondroitin
sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354:795-808. |
|
|
|
|
|
11.
Shankland WE, 2nd. The effects of glucosamine and chondroitin sulfate on osteoarthritis of the TMJ: a preliminary report of 50 patients. Cranio.
1998;16:230-5. |
|
|
|
|
|
12.
Nguyen P, Mohamed SE, Gardiner
D, Salinas T. A randomized double-blind
clinical trial of the effect of chondroitin sulfate
and glucosamine hydrochloride
on temporomandibular joint disorders: a pilot study. Cranio. 2001;19:130-9. |
|
|
|
|
|
13.
Burch F, Fishman R,
Messina N, Corser B, Radulescu
F, Sarbu A, et al. A comparison
of the analgesic efficacy of Tramadol Contramid OAD versus placebo in patients
with pain due to osteoarthritis.
J Pain Symptom Manage. 2007;34:328-38. |
|
|
|
|
|
14.
Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum.
2000;43:1905-15. |
|
|
|
|
|
15.
van Laar M, Pergolizzi
JV, Mellinghoff HU, Merchante IM, Nalamachu S, O'Brien J, et al. Pain
treatment in arthritis-related
pain: beyond NSAIDs. Open Rheumatol J.
2012;6:320-30. |
|
|
|
|
|
16.
Wilkes CH. Internal derangements
of the temporomandibular joint. Pathological variations. Arch Otolaryngol Head Neck Surg. 1989;115:469-77. |
|
|
|
|
|
17.
Conti PC, de Azevedo LR,
de Souza NV, Ferreira FV. Pain measurement
in TMD patients: evaluation
of precision and sensitivity
of different scales. J
Oral Rehabil. 2001;28:534-9. |
|
|
|
|
|
18.
Tvrdy P, Heinz P, Pink R.
Arthrocentesis of the temporomandibular joint: A review. Biomed Pap Med Fac
Univ Palacky Olomouc Czech Repub. 2015;159:31-4. |
|
|
|
|
|
19.
Wake M, Hamada Y, Kumagai K, Tanaka
N, Ikeda Y, Nakatani Y,
et al. Up-regulation of interleukin-6 and vascular endothelial growth factor-A in the synovial fluid of temporomandibular joints affected by synovial
chondromatosis. Br J Oral Maxillofac
Surg. 2013;51:164-9. |
|
|
|
|
|
20.
Takano H, Ariyoshi W, Kanno T, Fukuhara E, Ichimiya H, Matayoshi T, et al.
Induction of osteoclast-like
cells derived from the synovial
lavage fluids of patients with temporomandibular joint disorders. Osteoarthritis Cartilage. 2007;15:291-9. |
|
|
|
|
|
21.
Kaneyama K, Segami N, Nishimura M, Suzuki T, Sato J. Importance
of proinflammatory cytokines
in synovial fluid from
121 joints with temporomandibular disorders. Br
J Oral Maxillofac Surg.
2002;40:418-23. |
|
|
|
|
|
22.
Kaneyama K, Segami N, Sun W, Sato J, Fujimura K. Analysis of tumor necrosis factor-alpha,
interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor,
interleukin-1 soluble receptor type II, interleukin-1
receptor antagonist, and protein
in the synovial fluid of patients with temporomandibular joint disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:276-84. |
|
|
|
|
|
23.
Quinn JH, Bazan NG. Identification of prostaglandin
E2 and leukotriene B4 in the
synovial fluid of painful,
dysfunctional temporomandibular
joints. J Oral Maxillofac
Surg. 1990;48:968-71. |
|
|
|
|
|
24.
Mazieres B, Hucher M, Zaim M, Garnero P. Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled
study. Ann Rheum Dis. 2007;66:639-45. |
|
|
|
|
|
25.
Chan PS, Caron JP, Rosa GJ, Orth
MW. Glucosamine and chondroitin
sulfate regulate gene expression
and synthesis of nitric
oxide and prostaglandin E(2) in articular cartilage explants. Osteoarthritis Cartilage.
2005;13:387-94. |
|
|
|
|
|
26.
Bruyere O, Reginster JY. Glucosamine and chondroitin
sulfate as therapeutic agents
for knee and hip osteoarthritis. Drugs Aging. 2007;24:573-80. |
|
|
|
|
|
27.
Simanek V, Kren V, Ulrichova J, Gallo J. The efficacy of glucosamine and chondroitin sulfate in the treatment of osteoarthritis:
are these saccharides drugs or nutraceuticals?
Biomed Pap Med Fac Univ
Palacky Olomouc Czech Repub. 2005;149:51-6. |
|
|
|
|
|
28.
Chan PS, Caron JP, Orth
MW. Effects of glucosamine
and chondroitin sulfate on
bovine cartilage explants under long-term culture conditions.
Am J Vet Res. 2007;68:709-15. |
|
|
|
|
|
29.
Kean WF, Bouchard S, Roderich Gossen E. Women with pain
due to osteoarthritis: the efficacy and safety of a once-daily
formulation of tramadol. Pain Med. 2009;10:1001-11. |
|
|
|
|
|
30.
Furlan AD, Sandoval JA, Mailis-Gagnon
A, Tunks E. Opioids for chronic noncancer
pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006;174:1589-94. |
|
|
|
|
|
31.
Lanier RK, Lofwall MR, Mintzer MZ, Bigelow GE, Strain EC. Physical dependence potential of daily tramadol dosing in humans. Psychopharmacology (Berl).
2010;211:457-66. |
|
|
|
|